Pancreatic Cancer Research

ResearcherEast Carolina UniversityActive in the last 2 years

Szu-Aun Lim

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5552-7115; OpenAlex author ID A5103281359, A5113424876. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 3

  1. CRISPR-Cas9 Screening Identifies Resistance Mechanisms to KRAS Inhibition in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-25-1835↗
  2. Evaluation of KRAS inhibitor-directed therapies for pancreatic cancer treatment. Co-author DOI 10.3389/fonc.2024.1402128↗
  3. Opportunity Costs of Surgical Resection and Perioperative Chemotherapy for Locoregional Pancreatic Adenocarcinoma. Co-author DOI 10.1200/op.21.00311↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Andrew M. Waters · 2 shared papers, 2024–2026 · strength 0.49
  2. Syed Ameen Ahmad · 1 shared paper, 2024 · strength 0.28
  3. A. Cole Edwards · 1 shared paper, 2026 · strength 0.21
  4. Julien Dilly · 1 shared paper, 2026 · strength 0.21
  5. Syed Arif Ahmad · 1 shared paper, 2026 · strength 0.21
  6. Kirsten L. Bryant · 1 shared paper, 2026 · strength 0.21
  7. Adrienne D. Cox · 1 shared paper, 2026 · strength 0.21
  8. Sarah E. Ackermann · 1 shared paper, 2026 · strength 0.21
  9. Andrew J. Aguirre · 1 shared paper, 2026 · strength 0.21
  10. Clint A. Stalnecker · 1 shared paper, 2026 · strength 0.21
  11. Channing J. Der · 1 shared paper, 2026 · strength 0.21
  12. G. Aaron Hobbs · 1 shared paper, 2026 · strength 0.21
  13. Craig M. Goodwin · 1 shared paper, 2026 · strength 0.21
  14. Anastasios T. Mitsakos · 1 shared paper, 2022 · strength 0.16
  15. Alexander A. Parikh · 1 shared paper, 2022 · strength 0.16
  16. Scarlett B. Hao · 1 shared paper, 2022 · strength 0.16
  17. Rebecca Anne Snyder · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.